Thoracic Fluid Content by Electrical Cardiometry Versus Lung Ultrasound in Mechanically Ventilated Patients
1 other identifier
observational
85
1 country
1
Brief Summary
This study aims to compare the accuracy of the total thoracic fluid content (TFC) measured by electrical cardiometry with accuracy of lung ultrasound score in prediction of weaning outcome in mechanically ventilated patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Mar 2022
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 14, 2022
CompletedFirst Posted
Study publicly available on registry
March 10, 2022
CompletedStudy Start
First participant enrolled
March 25, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 25, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
December 25, 2023
CompletedApril 15, 2025
April 1, 2025
1.8 years
February 14, 2022
April 12, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Comparing the area under the curve (AUC) of receiver operating characteristic (ROC) for thoracic fluid content (TFC) and lung ultrasound score.
Comparing the area under the curve (AUC) of receiver operating characteristic (ROC) for thoracic fluid content (TFC) and lung ultrasound score (minimum score, normal lungs: 0; maximum score, both consolidated lungs: 36) in prediction of weaning outcome in mechanically ventilated patients.
Two days after the extubation
Secondary Outcomes (3)
Prediction of weaning through rapid shallow breathing index (RSBI)
Two days after the extubation
The degree of lung compliance
Before initiation of spontaneous breathing trial and before extubation.
Cumulative fluid balance
within 24 hours of spontaneous breathing trial
Study Arms (2)
Successful weaning group
Criteria of weaning included resolution of the primary cause of intubation, adequate cough without excessive tracheobronchial secretions, PaO2 \> 60 mmHg with positive end-expiratory pressure ≤ 8 cmH2O, fraction of inspired oxygen ≤ 0.4, respiratory rate \< 30 per minute, appropriate pH for patients' baseline respiratory status, and stable cardiovascular status.
Failed weaning group
Weaning failure will be defined as a patient need for reintubation or noninvasive ventilation within 48 h after extubation due to the presence of one or more of the following criteria: altered mental status tachypnea (respiratory rate more than 35 breaths per minute), oxygen saturation less than 90% or PaO2 less than 60 mmHg on a fraction of inspired oxygen of 40%, an apparent increase in accessory respiratory muscle activity, evident facial signs of respiratory distress and hemodynamic instability (Heart rate \>140 b/min, systolic blood pressure \>180 or \< 90mmHg )
Interventions
Thoracic fluid content will be measured using electrical cardiometry device (ICON ® Cardiotronics, Inc., La Jolla, CA 92307; Osyka Medical GmbH, Berlin, and Germany, model C3, Serial no: 1725303). The ICON device will be connected to four electrocardiogram electrodes which will be placed over patients' skin after cleaning with alcohol at the neck below the left ear, just above the left clavicular midpoint, and two electrodes at left mid-axillary line one at the level of the xiphoid process, and the other electrode 5 cm below this point. The thoracic fluid content will be observed for 30 s and the average of the highest and lowest values will be recorded.
The 12-region technique for lung assessment will be performed using Philips ® (CX50 - Extreme edition) equipped with phased array transducer. B-line will be defined as laser like vertical hyperechoic artefact which extends between the pleural line and the bottom of the screen and moves with respiratory movements. Two types of B-lines will be evaluated.
Eligibility Criteria
85 mechanically ventilated patients for ≥ 48 hours aged 18 years or more of both sex who fulfilled the weaning readiness criteria and scheduled for spontaneous breathing trial using pressure support ventilation.
You may qualify if:
- mechanically ventilated patients for ≥ 48 hours
- Aged 18-65 years
- Both sex
- Fulfilled the weaning readiness criteria
- Scheduled for spontaneous breathing trial (SBT) using pressure support ventilation.
You may not qualify if:
- Acute respiratory distress syndrome (ARDS) patients.
- Interstitial lung fibrosis.
- Patients with lung resection.
- Pulmonary embolism.
- Patients with fluid overload due to heart, renal or hepatic failure.
- Cardiac patients with ejection fraction less than 40%, cardiomyopathy, congenital or valvular heart diseases.
- Pneumothorax.
- Pleural or pericardial effusion.
- Pregnancy.
- Patients with injuries, burns, or wounds which precluded the proper application of the device electrodes or the ultrasound transducer.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Tanta Universitylead
Study Sites (1)
Tanta University
Tanta, El-Gharbia Governorate, Egypt, 31527, Egypt
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 2 Days
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant lecturer of Anesthesiology, Surgical Intensive Care and Pain Management
Study Record Dates
First Submitted
February 14, 2022
First Posted
March 10, 2022
Study Start
March 25, 2022
Primary Completion
December 25, 2023
Study Completion
December 25, 2023
Last Updated
April 15, 2025
Record last verified: 2025-04
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL
- Time Frame
- The data will be available after the study and for 5 years after.
The data will be available upon reasonable request from the corresponding author.